India Begins Subjecting Liquid Medicines To Retail Price Caps
This article was originally published in PharmAsia News
Executive Summary
All liquid medicines in India, including antibiotics and multivitamins, are to be subjected to price caps for the first time by the National Pharmaceutical Pricing Authority. Medicines in liquid form account for 15 percent of the retail market in India, and producers include all domestic drug makers. The drug-pricing authority has notified makers of the maximum retail prices set for 16 medicines that use any of 74 bulk drugs subject to price controls. The NPPA is preventing companies from avoiding the caps by covering all possible pack sizes up to 500ml. (Click here for more